| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |